INDIRECT RECOGNITION OF DONOR HLA CLASS I PEPTIDES IN LUNG TRANSPLANT RECIPIENTS WITH BRONCHIOLITIS OBLITERANS SYNDROME1
- 1 April 1999
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 67 (8) , 1094-1098
- https://doi.org/10.1097/00007890-199904270-00002
Abstract
The presentation of donor MHC class II-derived peptides by host antigen-presenting cells in the context of self-MHC class II molecules has been suggested as a mechanism for the chronic rejection of kidney and heart allografts. The aim of this study was to determine whether indirect allorecognition of HLA class I-derived peptides occurred in lung transplant (LTx) recipients and whether it correlated with the development of bronchiolitis obliterans syndrome (BOS). Peripheral blood mononuclear cells from LTx recipients were cultured with synthetic peptides corresponding to the hypervariable regions of the mismatched HLA class I antigens of the donor. Proliferation and precursor frequency (PF) of allopeptide reactive T cells were determined by the incorporation of [3H]thymidine into DNA and limiting dilution analysis. Peripheral blood leukocytes of LTx recipients with BOS mismatched for HLA class I molecules showed a proliferative response three- to fourfold higher than those observed in mismatched recipients without BOS and in normal control individuals (P<0.001). Similarly, the PF of allopeptide-reactive T cell was 3- to 24-fold higher in recipients with BOS compared with recipients without BOS (P<0.05) as well as normal control individuals (P<0.03). The T cell PF to donor-specific allopeptides, as well as irrelevant allopeptides, was not significantly different in LTx recipients without BOS and normal control individuals. These data suggest that T cells from LTx recipients are sensitized to mismatched HLA class I antigens. The sensitization was significantly higher in LTx recipients with BOS compared with LTx recipients without BOS. Strategies to block T-cell responses generated by indirect allorecognition after lung transplantation may provide a means for the prevention or treatment of BOS in LTx recipients.Keywords
This publication has 30 references indexed in Scilit:
- MECHANISMS OF INDIRECT ALLORECOGNITIONTransplantation, 1998
- INDIRECT ALLORECOGNITION OF MAJOR HISTOCOMPATIBILITY COMPLEX ALLOPEPTIDES IN HUMAN RENAL TRANSPLANT RECIPIENTS WITH CHRONIC GRAFT DYSFUNCTION1Transplantation, 1997
- Indirect T-cell allorecognition: perspectives for peptide-based therapy in transplantation lImmunology Today, 1997
- INDIRECT T CELL ALLORECOGNITION OF DONOR ANTIGENS CONTRIBUTES TO THE REJECTION OF VASCULARIZED KIDNEY ALLOGRAFTSTransplantation, 1995
- Indirect presentation of MHC antigens in transplantationImmunology Today, 1994
- Contribution of direct and indirect recognition pathways to T cell alloreactivity.The Journal of Experimental Medicine, 1993
- Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides.The Journal of Experimental Medicine, 1992
- Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection.The Journal of Experimental Medicine, 1992
- Creation of H-2 class I epitopes using synthetic peptides: recognition by alloreactive cytotoxic T lymphocytes.Proceedings of the National Academy of Sciences, 1989
- H—2-restricted cytolytic T cells specific for HLA can recognize a synthetic HLA peptideNature, 1986